Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AAN releases new position statement on opioids for chronic non-cancer pain

According to a new position statement from the American Academy of Neurology, the risk of death, overdose, addiction or serious side effects with prescription opioids outweigh the benefits in chronic, non-cancer conditions such as headache, fibromyalgia and chronic low back pain.

30 Sep 2014

Research finding opens door to potential treatment for MPS IIIB

MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death -- often before reaching adulthood.

30 Sep 2014

Novel project to develop new models of care for depression in older adults

UC Davis and the University of Washington are implementing a project to develop innovative new models of care for depression in older adults through a $2.5 million grant from the California-based Archstone Foundation, a private grant-making organization whose mission is to contribute toward the preparation of society in meeting the needs of an aging population.

30 Sep 2014

Standard cognition test falls short in Parkinson’s disease patients

There is a wide range of cognitive function, including dementia, among patients with Parkinson’s disease who are classed as cognitively normal on the Mini-Mental State Examination, research shows.

29 Sep 2014

Research points to remote monitoring as offering way to improve patient care

An aging population and an increased incidence of debilitating illnesses such as Parkinson's and Alzheimer's disease means there is pressure on technology to offer assistance with healthcare - monitoring and treatment. Research published in the International Journal of Ad Hoc and Ubiquitous Computing points to remote monitoring as offering a way to improve patient care and even accelerate medical research.

29 Sep 2014

UCLA research may lead to novel treatment for PH1

Research by UCLA biochemists may lead to a new treatment - or even a cure - for PH1, a rare and potentially deadly genetic kidney disease that afflicts children. Their findings also may provide important insights into treatments for Parkinson's disease, Alzheimer's disease and other degenerative diseases.

27 Sep 2014

GSA and NAM select reporters for Journalists in Aging Fellows Program

The Gerontological Society of America (GSA) and New America Media (NAM) have selected 19 reporters for the Journalists in Aging Fellows Program, now in its fifth year.

26 Sep 2014

NeuroEM begins study to test Transcranial Electromagnetic Treatment in aged primates

NeuroEM Therapeutics, Inc., a Phoenix-based medical device R&D company, announced today that it has begun a study with a premiere research university to test its Transcranial Electromagnetic Treatment (TEMT) in aged primates.

25 Sep 2014

Self-reported memory complaints are strong predictors of Alzheimer's later in life

New research by scientists at the University of Kentucky's Sanders-Brown Center on Aging suggests that people who notice their memory is slipping may be on to something.

25 Sep 2014

UI study offers good news for care givers, health care providers

A new University of Iowa study further supports an inescapable message: caregivers have a profound influence-good or bad-on the emotional state of individuals with Alzheimer's disease.

25 Sep 2014

People with memory loss more likely to develop dementia later, study finds

New research suggests that people without dementia who begin reporting memory issues may be more likely to develop dementia later, even if they have no clinical signs of the disease.

25 Sep 2014

Northwestern scientists develop first animal model for ALS dementia

The first animal model for ALS dementia, a form of ALS that also damages the brain, has been developed by Northwestern Medicine- scientists. The advance will allow researchers to directly see the brains of living mice, under anesthesia, at the microscopic level. This will allow direct monitoring of test drugs to determine if they work.

25 Sep 2014

ACT for NIH seeks significant funding increase to enhance life-saving medical research

ACT for NIH: Advancing Cures Today announced a national, non-partisan effort to seek an immediate, significant funding increase for the National Institutes of Health (NIH) to enhance life-saving medical research for patients around the world.

24 Sep 2014

Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Chemists at the University of Leicester have reported a breakthrough in techniques to develop new drugs in the fight against diseases such as cancer and Alzheimer's.

24 Sep 2014

Hospitals seek to control costs by setting standards for care

One group in Delaware looked at high spending on cardiac monitoring for patients who really didn't need it and encouraged doctors to instead use guidelines from the American Heart Association. Costs fell by 70 percent for the monitoring, a study finds.

24 Sep 2014

Researchers demonstrate how Parkinson's disease spreads in the human brain

An international, interdisciplinary group of researchers led by Gabor G. Kovacs from the Clinical Institute of Neurology at the MedUni Vienna has demonstrated, through the use of a new antibody, how Parkinson's disease spreads from cell to cell in the human brain.

23 Sep 2014

Experts to study how improved support for dementia carers can enhance quality of life

Experts will explore how improved support and powers for people caring for loved-ones with dementia can improve quality of life for both patients and carers around the UK.

23 Sep 2014

Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

York University researchers say a simple test that combines thinking and movement can help to detect heightened risk for developing Alzheimer's disease in a person, even before there are any telltale behavioural signs of dementia.

23 Sep 2014

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

TauRx Therapeutics Ltd has achieved its target enrolment of 700 subjects with mild Alzheimer's disease into the second of its two Phase III clinical trials of LMTX, a tau aggregation inhibitor, for the treatment of Alzheimer's disease.

22 Sep 2014

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

Researchers at Jacksonville's campus of Mayo Clinic have discovered a defect in a key cell-signaling pathway they say contributes to both overproduction of toxic protein in the brains of Alzheimer's disease patients as well as loss of communication between neurons - both significant contributors to this type of dementia.

21 Sep 2014

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

AAN releases new position statement on opioids for chronic non-cancer pain

Research finding opens door to potential treatment for MPS IIIB

Novel project to develop new models of care for depression in older adults

Standard cognition test falls short in Parkinson’s disease patients

Research points to remote monitoring as offering way to improve patient care

UCLA research may lead to novel treatment for PH1

GSA and NAM select reporters for Journalists in Aging Fellows Program

NeuroEM begins study to test Transcranial Electromagnetic Treatment in aged primates

Self-reported memory complaints are strong predictors of Alzheimer's later in life

UI study offers good news for care givers, health care providers

People with memory loss more likely to develop dementia later, study finds

Northwestern scientists develop first animal model for ALS dementia

ACT for NIH seeks significant funding increase to enhance life-saving medical research

Leicester scientists lend a helping hand in fight against Alzheimer's and cancer

Hospitals seek to control costs by setting standards for care

Researchers demonstrate how Parkinson's disease spreads in the human brain

Experts to study how improved support for dementia carers can enhance quality of life

Simple test based on movement and thought can help identify Alzheimer's risk before signs of dementia

TauRx achieves target enrolment in second LMTX Phase III clinical trial for Alzheimer's disease

Researchers discover key cell-signaling pathway that contributes to development of Alzheimer's disease

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in